Cancer Molecular Pathology Training Program

癌症分子病理学培训项目

• 批准号: 6514695
• 负责人: FREDERIC G BARR
• 金额: $ 36.19万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-06-06 至 2006-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6514695
• 关键词: curriculum; education evaluation /planning; molecular pathology; neoplasm /cancer education; neoplasm /cancer genetics; training

DESCRIPTION (provided by applicant): The overall goal of the field of cancer molecular pathology is the identification, analysis, and application of molecular markers relevant to cancer susceptibility, diagnosis, prognosis, monitoring, or therapy. As this young interdisciplinary field grows and evolves, there is a clear need to develop novel mechanisms to provide customized training experiences for postdoctoral physician-scientists. These training experiences need to provide a strong educational background that stresses the interrelationships among the participating disciplines that include tumor biology, pathology, oncology, genetics, and quantitative biology. Furthermore, such training experiences must provide in-depth exposure to an interdisciplinary research environment that requires interactive collaboration among biologists, pathologists, oncologists, and other specialists. To create this important training mechanism at the University of Pennsylvania, the Department of Pathology and Laboratory Medicine in conjunction with the University of Pennsylvania Cancer Center is proposing the implementation of a Cancer Molecular Pathology Training Program. The objective of this training program is to permit individuals with clinical training in pathology, oncology, or related fields to obtain basic education and develop research skills necessary for the validation and translation of cancer molecular information into clinical tests for cancer risk assessment, screening, diagnosis, prognosis, minimal disease assessment and therapeutic response prediction. These interdisciplinary didactic and research experiences will be facilitated by organization of a program faculty consisting of tumor biologists, pathologists, oncologists, molecular geneticists, and quantitative biologists. Trainees of this program will be prepared for an academic career in cancer molecular pathology by: 1) coursework in a specialized curriculum; 2) research training that involves completion of an interdisciplinary research project under the supervision of multiple mentors from the participating disciplines; and 3) publication, presentation and grantsmanship training. This innovative program will build on the considerable existing strengths at the University of Pennsylvania in pathology, genetics and cancer, with an established environment of interdisciplinary interactions among the Department of Pathology and Laboratory Medicine, the Cancer Center, the Center for Clinical Epidemiology and Biostatistics and other academic units.

描述（由申请人提供）：癌症领域的总体目标 分子病理是鉴定，分析和应用的 与癌症易感性，诊断，预后相关的分子标志物， 监测或治疗。 随着这个年轻的跨学科领域的成长， 不断发展，很明显需要开发新的机制来提供 博士后医师科学家的定制培训经验。 这些 培训经验需要提供强大的教育背景 强调参与学科之间的相互关系 包括肿瘤生物学，病理学，肿瘤学，遗传学和定量 生物学。 此外，这种培训经验必须提供深入 暴露于需要的跨学科研究环境 生物学家，病理学家，肿瘤学家和 其他专家。 在建立这种重要的训练机制 宾夕法尼亚大学病理与实验室 医学与宾夕法尼亚大学癌症中心结合 提出实施癌症分子病理训练计划。 该培训计划的目的是允许患有临床的人 病理学，肿瘤学或相关领域的培训以获得基础教育 并培养验证和翻译所需的研究技能 癌症分子信息进入临床测试以进行癌症风险评估， 筛查，诊断，预后，最少的疾病评估和治疗 响应预测。 这些跨学科的教学和研究 课程教师的组织将促进经验 由肿瘤生物学家，病理学家，肿瘤学家，分子组成 遗传学家和定量生物学家。 该计划的学员将是 为癌症分子病理学的学术生涯做准备：1） 专业课程的课程工作； 2）涉及的研究培训 在监督下完成一个跨学科研究项目 来自参与学科的多个导师； 3）出版， 演讲和赠款培训。 这个创新的计划将构建 关于宾夕法尼亚大学的现有优势 病理学，遗传学和癌症，具有既定环境 病理学和 实验室医学，癌症中心，临床流行病学中心 以及生物统计学和其他学术单位。